Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001628280-22-028752
Filing Date
2022-11-08
Accepted
2022-11-08 07:06:15
Documents
105
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 6-K adc-20220930.htm   iXBRL 6-K 259266
2 EX-99.1 adc-20220930_d2.htm   iXBRL EX-99.1 1720540
3 EX-99.2 adct-20220930x6kex992.htm EX-99.2 352049
4 EX-99.3 adct-20220930ex993.htm EX-99.3 190882
10 image_4.jpg GRAPHIC 20773
  Complete submission text file 0001628280-22-028752.txt   10769159

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT adc-20220930.xsd EX-101.SCH 108967
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT adc-20220930_cal.xml EX-101.CAL 83256
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT adc-20220930_def.xml EX-101.DEF 446174
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT adc-20220930_lab.xml EX-101.LAB 802776
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT adc-20220930_pre.xml EX-101.PRE 605445
99 EXTRACTED XBRL INSTANCE DOCUMENT adc-20220930_htm.xml XML 2016958
Mailing Address BIOPOLE ROUTE DE LA CORNICHE 3B EPALINGES V8 1066
Business Address BIOPOLE ROUTE DE LA CORNICHE 3B EPALINGES V8 1066 41 21 653 02 00
ADC Therapeutics SA (Filer) CIK: 0001771910 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39071 | Film No.: 221367181
SIC: 2834 Pharmaceutical Preparations